Credit Suisse’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$2 Sell
2022
Q3
$1K Buy
2022
Q2
$0 Buy
2021
Q4
Sell
2021
Q3
$1.23M Sell
2021
Q2
$3.74M Buy
2021
Q1
$5.18M Buy
2018
Q3
Sell
2018
Q2
$91K Sell
2018
Q1
$321K Buy
2017
Q4
Sell
2017
Q3
$166K Buy